October 4, 2023
Start of our Translational Seminar Series 2023: The ABC of Viral Hepatitis
Intensive exchange between research and clinic is essential for successful translation. With the translational seminar series “The ABC of Viral Hepatitis – from translational research to clinical practice” on the topic of hepatitis, we would like to take a closer look at the various steps that make up successful translation: the latest findings from research, current clinical studies, practical experience from the clinic as well as future-oriented developments in therapy. The series aims to facilitate and intensify the exchange between researchers and clinicians, and thus to strengthen cooperation in the long term.
The first seminar took place on 12 July 2023 with our D‑SOLVE partners Soo Aleman (Stockholm) and Pietro Lampertico (Milano). Held as a “Round table discussion on Delta Management & Updates from EASL Congress 2023” and chaired by Heiner Wedemeyer, it marked a great start with valuable insights and lively discussions.
The second seminar followed on 4 October 2023, focusing on the Epidemiology of Hepatitis Delta in Eastern Europe, Central Asia and Sub-Saharan Africa. Speakers were Florin Caruntu from the D‑SOLVE consortium (National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania), Malika Khodjaeva (Research Institute of Virology & Medical Academy, Tashkent, Uzbekistan) and Ijeoma Ifeorah (Center for Translation and Implementation Research, Enugu, Nigeria). Participants gained an in‑depth understanding of region‑specific challenges and discussed necessary steps towards improving disease management in these settings.
The seminar series continued on 14 December 2023 with a lecture by Thomas Baumert (Université de Strasbourg / Inserm, France; member of the D‑SOLVE consortium) entitled “Therapeutic vaccination”. His presentation provided important insights into current therapeutic vaccination strategies and emphasized the crucial role of close cooperation between fundamental research and clinical application in driving innovation forward.
October 4, 2023
Start of our Translational Seminar Series 2023: The ABC of Viral Hepatitis
Intensive exchange between research and clinic is essential for successful translation. With the translational seminar series “The ABC of Viral Hepatitis – from translational research to clinical practice” on the topic of hepatitis, we would like to take a closer look at the various steps that make up successful translation: the latest findings from research, current clinical studies, practical experience from the clinic as well as future-oriented developments in therapy. The series aims to facilitate and intensify the exchange between researchers and clinicians, and thus to strengthen cooperation in the long term.
The first seminar took place on 12 July 2023 with our D‑SOLVE partners Soo Aleman (Stockholm) and Pietro Lampertico (Milano). Held as a “Round table discussion on Delta Management & Updates from EASL Congress 2023” and chaired by Heiner Wedemeyer, it marked a great start with valuable insights and lively discussions.
The second seminar followed on 4 October 2023, focusing on the Epidemiology of Hepatitis Delta in Eastern Europe, Central Asia and Sub-Saharan Africa. Speakers were Florin Caruntu from the D‑SOLVE consortium (National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania), Malika Khodjaeva (Research Institute of Virology & Medical Academy, Tashkent, Uzbekistan) and Ijeoma Ifeorah (Center for Translation and Implementation Research, Enugu, Nigeria). Participants gained an in‑depth understanding of region‑specific challenges and discussed necessary steps towards improving disease management in these settings.
The seminar series continued on 14 December 2023 with a lecture by Thomas Baumert (Université de Strasbourg / Inserm, France; member of the D‑SOLVE consortium) entitled “Therapeutic vaccination”. His presentation provided important insights into current therapeutic vaccination strategies and emphasized the crucial role of close cooperation between fundamental research and clinical application in driving innovation forward.
October 4, 2023
Start of our Translational Seminar Series 2023: The ABC of Viral Hepatitis
Intensive exchange between research and clinic is essential for successful translation. With the translational seminar series “The ABC of Viral Hepatitis – from translational research to clinical practice” on the topic of hepatitis, we would like to take a closer look at the various steps that make up successful translation: the latest findings from research, current clinical studies, practical experience from the clinic as well as future-oriented developments in therapy. The series aims to facilitate and intensify the exchange between researchers and clinicians, and thus to strengthen cooperation in the long term.
The first seminar took place on 12 July 2023 with our D‑SOLVE partners Soo Aleman (Stockholm) and Pietro Lampertico (Milano). Held as a “Round table discussion on Delta Management & Updates from EASL Congress 2023” and chaired by Heiner Wedemeyer, it marked a great start with valuable insights and lively discussions.
The second seminar followed on 4 October 2023, focusing on the Epidemiology of Hepatitis Delta in Eastern Europe, Central Asia and Sub-Saharan Africa. Speakers were Florin Caruntu from the D‑SOLVE consortium (National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania), Malika Khodjaeva (Research Institute of Virology & Medical Academy, Tashkent, Uzbekistan) and Ijeoma Ifeorah (Center for Translation and Implementation Research, Enugu, Nigeria). Participants gained an in‑depth understanding of region‑specific challenges and discussed necessary steps towards improving disease management in these settings.
The seminar series continued on 14 December 2023 with a lecture by Thomas Baumert (Université de Strasbourg / Inserm, France; member of the D‑SOLVE consortium) entitled “Therapeutic vaccination”. His presentation provided important insights into current therapeutic vaccination strategies and emphasized the crucial role of close cooperation between fundamental research and clinical application in driving innovation forward.
